iPad monitored pacemaker latest AI advance

May 14, 2019

Rapid advances in technology including robotics and the Internet of Things are transforming traditional health care delivery. These innovations, including wearable devices and subcutaneous monitors are connecting patients and mobile devices to their doctors.

The catalyst is the rapidly evolving digitization of patient information, including CT scans and X-rays. As more of the information is moved online, assessments can be more easily shared and coordinated on computers mobile phones and tablets.

One recent example is the approval by the US Food and Drug Administration (FDA) of a device manager developed by Medtronic Corp.  Medtronic (NYSE:MDT) is the world’s largest medical device company. It operates in 140 countries and employs over 86,000 people, but generates most of its sales and profits in the U.S. 

The device manager helps doctors monitor pacemakers and other implanted cardiac devices via a wireless internet connection. Doctors use a dedicated iPad to receive signals and monitor data from a patient’s pacemaker to ensure that it is functioning properly and that the patient’s vital signs are stable.

As reported in MD Magazine, the device manager is simple to use and weighs about 2 lbs. The software includes a mobile application that allows for direct patient-to-physician data sharing.

The device manager complements the January 2019 launch of a mobile app which allows patients to use  Bluetooth technology to communicate with their  cardiac devices. The new device manager uses the app to link the devices.


The device manager has been approved in 20 countries and will be fully launched in the U.S. markets this year. The wireless capabilities and data transfer options will help physicians get lab results faster and potentially allow for them to interact more with patients and colleagues.

Medtronic is a top holding of the Harvest Portfolio Group Inc.’s Harvest Healthcare Leaders Income ETF (HHL:TSX, HHL.U:TSX). 

The ETF had 20 stocks as of April 30, 2019, all global healthcare leaders with a minimum market capitalization of US$5 billion.  The ETF has $347.7 million CAD in assets under management and a management fee of 0.85%. – AM

For more on Harvest Portfolio Group Inc.’s investment products, click here.

 

The views and/or opinions expressed in the blog are of a general nature and are for informational purposes only. Blog contents should not be considered as advice and/or a recommendation to purchase or sell the mentioned securities or used to engage in personal investment strategies. Investors should consult their investment advisor before making any investment decision. 

 

You may also like…

Disclaimer

You will usually pay brokerage fees to your dealer if you purchase or sell units of the Fund(s) on the TSX. If the units are purchased or sold on the TSX, investors may pay more than the current net asset value when buying units of the Fund(s) and may receive less than the current net asset value when selling them. There are ongoing fees and expenses associated with owning units of an investment fund. Investment funds are not guaranteed, their values change frequently and past performance may not be repeated. An investment fund must prepare disclosure documents that contain key information about the fund. You can find more detailed information about the fund in these documents.

Certain statements in the Harvest Blog are forward looking Forward-looking statements (“FLS”) are statements that are predictive in nature, depend upon or refer to future events or conditions, or that include words such as “may,” “will,” “should,” “could,” “expect,” “anticipate,” “intend,” “plan,” “believe,” or  “estimate,” or other similar expressions. Statements that look forward in time or include anything other than historical information are subject to risks and uncertainties, and actual results, actions or events could differ materially from those set forth in the FLS.

FLS are not guarantees of future performance and are by their nature based on numerous assumptions, which include, amongst other things, that (i) the Fund can attract and maintain investors and have sufficient capital under management to effect their investment strategies, (ii) the investment strategies will produce the results intended by the portfolio managers, and (iii) the markets will react and perform in a manner consistent with the investment strategies. Although the FLS contained herein are based upon what the portfolio manager believe to be reasonable assumptions, the portfolio manager cannot assure that actual results will be consistent with these FLS.

Unless required by applicable law, Harvest Portfolios Group Inc. does not undertake, and specifically disclaim, any intention or obligation to update or revise any FLS, whether as a result of new information, future events or otherwise.

Subscribe to our newsletter and stay informed

Join Us & Stay Informed!

* indicates required

Your Preferences   (Please select all the ways you would like to hear from)


You are a *


Confirm *


Join Us & Stay Informed!

* indicates required

Your Preferences   (Please select all the ways you would like to hear from)


You are a *


Confirm *